Release from Minapharm Pharmaceuticals (MIPH.CA) Regarding the Financial Statements
Company Name : Minapharm Pharmaceuticals
ISIN Code : EGS380G1C011
Reuters Code : MIPH.CA
Content :
Release from the company regarding the reasons for the delay in submitting the standalone and consolidated financial statements for the financial period ending on 31/03/2026 beyond the due date.
Release from the Company (222 KB)
ISIN Code : EGS380G1C011
Reuters Code : MIPH.CA
Content :
Release from the company regarding the reasons for the delay in submitting the standalone and consolidated financial statements for the financial period ending on 31/03/2026 beyond the due date.
Release from the Company (222 KB)
Comments